The BRCT domain from the homologue of the oncogene PES1 in Leishmania major (LmjPES) promotes malignancy and drug resistance in mammalian cells

by Larrea, E. (Esther), Fernández-Rubio, C. (Celia), Peña-Guerrero, J. (José), Guruceaga, E. (Elizabeth), Nguewa, P.A. (Paul Alain)
Published 2022

LmjF.22.0810 from Leishmania major Modulates the Th2-Type Immune Response and Is Involved in Leishmaniasis Outcome

by Vacas, A. (Andrés), Fernández-Rubio, C. (Celia), Larrea, E. (Esther), Peña-Guerrero, J. (José), Nguewa, P.A. (Paul Alain)
Published 2023

Berberine-Loaded Liposomes for the Treatment of Leishmania infantum-Infected BALB/c Mice

by Calvo, A. (Alba), Moreno, E. (Esther), Larrea, E. (Esther), Sanmartin-Grijalba, C. (Carmen), Irache, J.M. (Juan Manuel), Espuelas, S. (Socorro)
Published 2023

Effect of topical berberine in murine cutaneous leishmaniasis lesions

by Calvo, A. (Alba), Moreno, E. (Esther), Aldalur, I. (Irati), Sanmartin-Grijalba, C. (Carmen), Larrea, E. (Esther), Gonzalez-Peñas, E. (Elena), Irache, J.M. (Juan Manuel), Espuelas, S. (Socorro)
Published 2022

The novel serine/threonine protein kinase LmjF.22.0810 from leishmania major may be involved in the resistance to drugs such as paromomycin

by Vacas, A. (Andrés), Fernández-Rubio, C. (Celia), Algarabel, M. (Miriam), Peña-Guerrero, J. (José), Larrea, E. (Esther), Formiga, F.R. (Fabio R.), García-Sosa, A.T. (Alfonso T.), Nguewa, P.A. (Paul Alain)
Published 2022

Repurposing the antibacterial agents peptide 19-4LF and peptide 19-2.5 for treatment of cutaneous leishmaniasis

by El-Dirany, R. (Rima), Fernández-Rubio, C. (Celia), Peña-Guerrero, J. (José), Moreno-Amatria, E. (Esther), Larrea, E. (Esther), Espuelas, S. (Socorro), Abdel-Sater, F. (Fadi), Brandenburg, K. (Klaus), Martinez-de-Tejada, G. (Guillermo), Nguewa, P.A. (Paul Alain)
Published 2022